author-photo

Katja Kaipio

University of Turku

45

Papers

473

Citations

Citation Trend

Filter By

Papers (30) Sort By

Journal Conference Others

Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (0)
Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
PRISM: Recovering cell type specific expression profiles from individual composite RNA-seq samples.

2021 Bioinformatics
Show All
- Source
- Cite
- Save
Citations (2)
Ovarian cancers with low CIP2A tumor expression constitute an APR-246 sensitive disease subtype

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Agile workflow for interactive analysis of mass cytometry data

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Analysis of single-cell RNA-seq data from ovarian cancer samples before and after chemotherapy links stress-related transcriptional profile withchemotherapy resistance

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
PRISM: Recovering cell type specific expression profiles from composite RNA-seq data

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

2019 The Journal of Pathology
Show All
- Source
- Cite
- Save
Citations (14)
Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells

2019 European Urology
Show All
- Source
- Cite
- Save
Citations (22)
Abstract B40: High-throughput screening of new potential targets for high-grade serous ovarian cancer treatment

2018 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)